Income Taxes

12 Months Ended

Dec. 31, 2024

Income Taxes.

Income Taxes

13. Income Taxes

The provision for income taxes was calculated based on the following components of earnings (loss) before income taxes:

	2024		2023		2022
U.S.	$	(284)	$	(455)	$	1
Non-U.S.		322		522		804
	$	38	$	67	$	805

The provision for income taxes consists of the following:

	2024		2023		2022
Current:
U.S.	$	13	$	13	$	14
Non-U.S.		106		114		142
		119		127		156
Deferred:
U.S.		—		(16)		(1)
Non-U.S.		7		41		23
		7		25		22
Total:
U.S.		13		(3)		13
Non-U.S.		113		155		165
	$	126	$	152	$	178

A reconciliation of the provision for income taxes based on the statutory U.S. Federal tax rate of 21% to the provision for income taxes is as follows:

	2024		2023		2022
Tax provision on pretax earnings at statutory U.S. Federal tax rate	$	8	$	14	$	169
Increase (decrease) in provision for income taxes due to:
Non-U.S. tax rates		12		5		34
Global intangible low taxed income and Foreign-derived intangible income, net of applicable GILTI credits		6		12		48
Goodwill impairment				85
Divestitures and sale leasebacks of land and building						(34)
Tax law changes		(1)		3		(1)
Tax impact of Brazil indirect tax ruling						(6)
Change in valuation allowance		34		85		(36)
Tax attribute expiration		17		7		6
Withholding tax		12		14		24
Non-deductible expenses and taxable gains		36		13		11
Tax credits and incentives		(24)		(34)		(25)
Changes in tax reserves and audit settlements		4		(14)		(4)
Mexico inflationary adjustments		(1)		(5)		(2)
Equity earnings		(17)		(23)		(20)
Intercompany financing		18		(13)		4
Other taxes based on income		6		6		5
Other items		16		(3)		5
Provision for income taxes	$	126	$	152	$	178

Deferred income taxes reflect: (1) the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their relevant tax basis; and (2) carryovers and credits for income tax purposes.

Significant components of the Company’s deferred tax assets and liabilities at December 31, 2024 and 2023 are as follows:

	2024		2023
Deferred tax assets:
Accrued postretirement benefits	$	23	$	23
Foreign tax credit carryovers		144		148
Operating, capital loss and interest carryovers		357		339
Other credit carryovers		29		27
Accrued liabilities		75		75
Pension liabilities		10		28
Operating lease liabilities		50		55
Other		61		86
Total deferred tax assets		749		781
Deferred tax liabilities:
Property, plant and equipment		113		119
Intangibles and deferred software		39		50
Operating lease right-of-use assets		48		53
Total deferred tax liabilities		200		222
Valuation allowance		(544)		(538)
Net deferred taxes	$	5	$	21

Deferred taxes are included in the Consolidated Balance Sheets at December 31, 2024 and 2023 as follows:

	2024		2023
Other assets	$	79	$	107
Deferred taxes		(74)		(86)
Net deferred taxes	$	5	$	21

The deferred tax expense associated with the increase in the valuation allowance of $6 million was primarily allocated $21 million income from continuing operations due to the primacy of continuing operations, changes in tax law and movements in non-U.S. currencies, and $15 million decrease to other comprehensive income.

Deferred tax assets and liabilities are determined separately for each tax jurisdiction on a separate or on a consolidated tax filing basis, as applicable, in which the Company conducts its operations or otherwise incurs taxable income or losses. A valuation allowance is recorded when it is more likely than not that some portion or all of the gross deferred tax assets will not be realized. The realization of deferred tax assets depends on the ability to generate sufficient taxable income of the appropriate character within the carryback or carryforward periods provided for in the tax law for each applicable tax jurisdiction. The Company considers the following possible sources of taxable income when assessing the realization of deferred tax assets:

●taxable income in prior carryback years;

●future reversals of existing taxable temporary differences;

●future taxable income exclusive of reversing temporary differences and carryforwards; and

●prudent and feasible tax planning strategies that the Company would be willing to undertake to prevent a deferred tax asset from otherwise expiring.

The assessment regarding whether a valuation allowance is required or whether a change in judgment regarding the valuation allowance has occurred also considers all available positive and negative evidence, including but not limited to:

●nature, frequency, and severity of cumulative losses in recent years;

●duration of statutory carryforward and carryback periods;

●statutory limitations against utilization of tax attribute carryforwards against taxable income;

●historical experience with tax attributes expiring unused; and

●near- and medium-term financial outlook.

The weight given to the positive and negative evidence is commensurate with the extent to which the evidence may be objectively verified. Accordingly, it is generally difficult to conclude a valuation allowance is not required when there is significant objective and verifiable negative evidence, such as cumulative losses in recent years. The Company uses the actual results for the last two years and current year results as the primary measure of cumulative losses in recent years.

The evaluation of deferred tax assets requires judgment in assessing the likely future tax consequences of events recognized in the financial statements or tax returns and future profitability. The recognition of deferred tax assets represents the Company’s best estimate of those future events. Changes in the current estimates, due to unanticipated events or otherwise, could have a material effect on the Company’s results of operations and financial condition.

In certain tax jurisdictions, the Company’s analysis indicates that it has cumulative losses in recent years. This is considered significant negative evidence, which is objective and verifiable and, therefore, difficult to overcome. However, the cumulative loss position is not solely determinative and, accordingly, the Company considers all other available positive and negative evidence in its analysis. Based on its analysis, the Company has recorded a valuation allowance for the portion of deferred tax assets where based on the weight of available evidence it is unlikely to realize those deferred tax assets.

Based on the evidence available including a lack of sustainable earnings, the Company in its judgment previously recorded a valuation allowance against substantially all of its net deferred tax assets in the United States. If a change in judgment regarding this valuation allowance were to occur in the future, the Company would record a potentially material deferred tax benefit, which could result in a favorable impact on the effective tax rate in that period. The utilization of tax attributes to offset taxable income reduces the amount of deferred tax assets subject to a valuation allowance. In addition, based on available evidence and the weighting of factors discussed above, the Company has valuation allowances on certain deferred tax assets in certain international tax jurisdictions.

At December 31, 2024, before valuation allowance, the Company had unused foreign tax credits of $144 million, including $58 million expiring in 2025 through 2033 and $86 million that can be carried over indefinitely. Approximately $288 million of the deferred tax assets related to operating, capital loss and interest

carryovers can be carried over indefinitely. The remaining operating, capital loss and interest carryforwards of $70 million expire between 2025 and 2044. Other credit carryovers include approximately $27 million of research tax credits expiring from 2025 to 2043.

Since a majority of the pre-2018 non-U.S. earnings (net of losses) were substantially taxed under the U.S. Tax Cuts and Jobs Act, distributions of those net earnings no longer attract significant U.S. income taxes except for any associated currency gains. Therefore, the Company does not assert that these net earnings (to the extent of foreign distributable reserves) and any associated gross book-tax basis differences, if any, are indefinitely reinvested. For all remaining gross book-tax basis differences in its non-U.S. consolidated subsidiaries, the Company maintains its assertion that it intends these to be indefinitely reinvested. The Company also records deferred foreign taxes on gross book-tax basis differences to the extent of foreign distributable reserves for certain foreign subsidiaries. Determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings is not practicable.

The Company records a liability for unrecognized tax benefits related to uncertain tax positions. The Company accrues interest and penalties associated with unrecognized tax benefits as a component of its income tax expense.

The following is a reconciliation of the Company’s total gross unrecognized tax benefits for the years ended December 31, 2024, 2023 and 2022:

	2024		2023		2022
Balance at January 1	$	41	$	53	$	95
Additions and reductions for tax positions of prior years				(15)		(10)
Additions based on tax positions related to the current year		5
Reductions due to the lapse of the applicable statute of limitations
Reductions due to settlements		(24)		(1)		(31)
Foreign currency translation		(1)		4		(1)
Balance at December 31	$	21	$	41	$	53
Unrecognized tax benefits, which if recognized, would impact the Company’s effective income tax rate	$	10	$	25	$	37
Accrued interest and penalties at December 31	$	2	$	9	$	8
Interest and penalties included in tax expense for the years ended December 31	$	(8)	$	1	$	(8)

Based upon the outcome of tax examinations, judicial proceedings, or expiration of statute of limitations, it is reasonably possible that the ultimate resolution of these unrecognized tax benefits may result in a payment that is materially different from the current estimate of the tax liabilities. The Company believes that it is reasonably possible that the estimated liability could decrease up to approximately $7 million within the next 12 months. This is primarily the result of anticipated audit settlements or statute expirations in several taxing jurisdictions.

The Company is currently under income tax examination in various tax jurisdictions in which it operates, including Brazil, Canada, Colombia, France, Germany, Hungary, Indonesia, Italy, Peru and the United States. The years under examination range from 2004 through 2023. The Company has received tax assessments in excess of established reserves. The Company is contesting these tax assessments, and will continue to do so, including pursuing all available remedies, such as appeals and litigation, if necessary.

The Company believes that adequate provisions for all income tax uncertainties have been made. However, if tax assessments are settled against the Company at amounts in excess of established reserves, it could have a material impact to the Company’s consolidated results of operations, financial position or cash flows. During 2024, the Company concluded income tax audits in several jurisdictions, including Brazil, Canada, France, Indonesia, Mexico and Peru.